Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "Shionogi"

Shionogi announces results from bacterial infection preclinica...

Shionogi & Co., Ltd., an R&D pharmaceutical company, has announced that S-649266, an investigational parenteral siderophore cephalosporin, exhibits marked potency against gram-negative bacteria, including multidrug-resistant, or MDR, pathogens, in ... Individual.com, 1 week ago

24 images for Shionogi

DesignCurial, 4 days ago
Pharma Letter, 1 week ago
DesignCurial, 2 weeks ago
DesignCurial, 2 weeks ago
DesignCurial, 2 weeks ago
DesignCurial, 2 weeks ago
DesignCurial, 2 weeks ago
DesignCurial, 2 weeks ago
DesignCurial, 2 weeks ago
DesignCurial, 2 weeks ago
Pharma Letter

MedImmune and Shionogi enter into license agreement for ACS biologic program

MedImmune, a biologics R&D arm of AstraZeneca, and Shionogi & Co., Ltd., a drug discovery-based pharmaceutical company, have entered into a license agreement under which MedImmune will in-license Shionogi's novel preclinical biologic program for the ...
 Individual.com1 week ago MedImmune in-licenses Shionogi biologic program in ACS  Drug Discovery News1 week ago MedImmune and Shionogi sign license agreement for Shionogi's preclinical biologics in acute coronary syndrome  Pharma Letter1 week ago AZ licenses ACS programme from old partner Shionogi  Big News Network1 week ago
[x]  

Shionogi handed hefty back-tax bill

OSAKA Tax authorities have notified drug maker Shionogi & Co. that it failed to report ¥40.5 billion in taxable income over a three-year period to March 2013. Given the Osaka Regional Taxation Bureau's decision, the firm said Friday it plans to ...
 Japan Times1 month ago Shionogi hit with ¥40 billion in back taxes over deal previously thought exempt  Japan Times1 month ago

C & O Pharmaceutical launches Rabeprazole Sodium for Injection in China

Shionogi & Co., Ltd., an R&D pharmaceutical company, has announced that C & O Pharmaceutical Technology Holdings Limited has launched Rabeprazole Sodium for Injection in China. Proton-pump inhibitors (PPIs) inhibit gastric acid secretion by blocking ...
 Individual.com2 weeks ago SHIONOGI : C&O Launches the First Rabeprazole Sodium for Injection (???®) in China  4 Traders3 weeks ago C&O Launches the First Rabeprazole Sodium for Injection (???®) in China  Noodls3 weeks ago Pragma Pharmaceuticals Announces Re-Launch of Moxatag®  Pharmacy Times1 month ago
4 Traders

Allergan and Shionogi to distribute eyelash hypotrichosis medication in Japan

Allergan Japan KK, a health care company, and Shionogi & Co., Ltd. have entered into joint sales agreement to distribute GlashVista cutaneous solution 0.03% 5ml for eyelash hypotrichosis treatment in Japan. Under this agreement, Allergan Japan will ...
 Individual.com1 month ago Evonik to expand specialty silica capacities in Japan  Business Standard India1 month ago Evonik Expands in Japan  Adhesives & Sealants Industry1 month ago Evonik's Specialty Silica Capacity to Expand in Japan, PPG Starts Marketing Campaign, Scientists Develop PLLA Nanosheets  Special Chem 4 Coatings1 month ago
[x]  

Shionogi said to have failed to report ¥40 bil. in income

Jiji Press OSAKA (Jiji Press) — Tax authorities have notified Shionogi & Co. that the major drug maker failed to report ¥40.5 billion in taxable income over three years to March 2013, the company said Friday. Following the notification by the ...
 The Japan News1 month ago
CRM Developer's Journal

Shionogi : Leverages BuzzeoPDMA's Services

BuzzeoPDMA reported that Shionogi Inc. has selected BuzzeoPDMA's sample management services. "Working with one vendor who can provide a number of different Sample Accountability and field-based inventory services has been a real benefit, and ...
 4 Traders1 month ago Shionogi Utilizes BuzzeoPDMA's Services  Individual.com1 month ago Shionogi & Co., Ltd. Enlists A Company To Support Their Sample Management Compliance Programs  BioSpace1 month ago Shionogi Inc. Enlists BuzzeoPDMA, a Cegedim Company to Support their Sample Management Compliance Programs  RCL Advisors1 month ago
[x]  

BioCryst defaults on debt

News Editor Citing an insufficient Rapiacta royalty stream from partner Shionogi & Co. to pay accrued interest in arrears on the non-recourse PharRMA Notes by the September 1, 2014 payment date, a BioCryst Pharmaceuticals (BCRX -0.8%) subsidiary ...
 Seeking Alpha1 month ago BIOCRYST PHARMACEUTICALS INC FILES (8-K) Disclosing Regulation FD Disclosure  Crawford Financial Planning1 month ago
[x]  

Shionogi Inc. Announces Four Abstracts To Be Presented At The 25th Annual Meeting Of The North American Menopause Society (NAMS) In Washington, DC

FLORHAM PARK, N.J. , Oct. 1, 2014 /PRNewswire/ -- Shionogi Inc., a global leader dedicated to women's health, will unveil four abstracts containing new analyses and safety and efficacy data from clinical trials of ospemifene (available in the U.S.
 Franklin Credit Management Corporation2 weeks ago Shionogi, Inc. Announces Four Abstracts To Be Presented At The In Washington, DC  BioSpace2 weeks ago
[x]  
Medical News Today

SHIONOGI : Presents Pre-Clinical and Phase I Results For S-649266, A Novel Siderophore Cephalosporine Antibiotic With Potential To Treat...

Shionogi Presents Pre-Clinical and Phase I Results For S-649266, A Novel Siderophore Cephalosporine Antibiotic With Potential To Treat Multidrug-Resistant Gram-Negative Pathogens By a News Reporter-Staff News Editor at Biotech Week -- -Findings ...
 4 Traders1 month ago Shionogi Presents Pre-Clinical and Phase I Results For S-649266, A Novel Siderophore Cephalosporine Antibiotic With Potential To Treat Multidrug-Resistant Gram-Negative Pathogens  Minyanville1 month ago Shionogi & Co., Ltd. Presents Pre-Clinical And Phase I Results For S-649266, A Novel Siderophore Cephalosporine Antibiotic With Potential To Treat Multidrug-Resistant Gram-Negative Pathogens  BioSpace1 month ago Novel Antibiotic Shows Potential for Broad Range of Infections  Biotech Daily4 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less